or
forgot password
  • cancer clinical trials in connecticut

  • Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale University
    Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor
    Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Treating Young Patients With Relapsed or Progressive Cancer
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Brain and Central Nervous System Tumors, Leukemia, Lymphoma, Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis Hospital and Medical Center
    Manchester Memorial Hospital
    Eastern Connecticut Hematology and Oncology Associates
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    A Study of Tarceva After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
    Hematology Oncology, P.C.

    Trial Locations
    Hematology Oncology, P.C.
    Connecticut Oncology & Hematology, LLP
    Non-small Cell Lung Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale University
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Bridgeport Hospital

    Trial Locations
    Bridgeport Hospital
    Bristol Hospital
    Praxair Cancer Center at Danbury Hospital
    Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Middlesex Hospital Cancer Center
    Norwalk Hospital
    Eastern Connecticut Hematology and Oncology Associates
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Connecticut Oncology & Hematology - Torrington
    Harold Leever Regional Cancer Center
    Breast Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Connecticut Oncology and Hematology LLP
    Torrington, Connecticut 06790
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale University
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale University
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Helen and Harry Gray Cancer Center at Hartford Hospital

    Trial Locations
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Eastern Connecticut Hematology and Oncology Associates
    Breast Cancer
    A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Pancreatic Cancer
    A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
    Bridgeport Hospital

    Trial Locations
    Bridgeport Hospital
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    Breast Cancer
    A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
    Yale University
    New Haven, Connecticut 06520
    Peripheral T-cell Lymphoma
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Yale Cancer Center
    Eastern Connecticut Hematology and Oncology Associates
    Veterans Affairs Medical Center - West Haven
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis Hospital and Medical Center
    Middlesex Hospital
    The Hospital of Central Connecticut
    Norwalk Hospital
    Stamford Hospital
    Connecticut Oncology and Hematology LLP
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale Cancer Center
    Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
    Research Site
    Danbury, Connecticut
    Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
    Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
    Celldex Investigational Site
    New Haven, Connecticut 06510
    Malignant Glioma
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific